Synthesis and biological evaluation of new active For-Met-Leu-Phe-OMe analogues containing para-substituted Phe residues

Journal of Peptide Science

Volumn 18, Issue 6, 2012, Pages 418-426

  Mollica, Adriano ^a   Feliciani, Federica ^a   Stefanucci, Azzurra ^a   Costante, Roberto ^a   Lucente, Gino ^b   Pinnen, Francesco ^a   Notaristefano, Daniela ^c   Spisani, Susanna ^c  

^a UNIVERSITY OF CHIETI   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

Author keywords

Biological activity; Chemotaxis; FMLF OMe analogues; Human neutrophils; Peptidomimetics; Receptor binding

Indexed keywords

LEUCINE; LYSOZYME; METHIONINE; PHENYLALANINE; SUPEROXIDE; TRIPEPTIDE;

AMINO ACID SUBSTITUTION; AMINO ACID SYNTHESIS; ARTICLE; BINDING AFFINITY; CHEMICAL STRUCTURE; CHEMOTAXIS; DOSE RESPONSE; ELECTRON; ENZYME ACTIVITY; ENZYME RELEASE; HUMAN; HUMAN CELL; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RECEPTOR AFFINITY; RECEPTOR BINDING;

AMINO ACID SEQUENCE; ANIONS; CHEMOTAXIS; HUMANS; MOLECULAR CONFORMATION; MURAMIDASE; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; OLIGOPEPTIDES; PHENYLALANINE; REFERENCE VALUES; STEREOISOMERISM; SUPEROXIDES;

EID: 84861230088     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.2414     Document Type: Article

References (29)

1. Carp H. Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils. J. Exp. Med. 1982; 85: 264-275.
2. Marasco WA, Phan SH, Krutzsch H, Showell HJ, Feltner DE, Nairn R, Becker EL, Ward PA. Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. J. Biol. Chem. 1984; 259: 5430-5439.
3. Seifert R, Wenzel-Seifert K. The human formyl peptide receptor as model system for constitutively active G-protein-coupled receptors. Life Sci. 2003; 73: 2263-2280.
4. Boulay F, Tardiff M, Brouchon L, Vignais P. Synthesis and use of a novel N-formyl peptide derivative to isolate a human N-formyl peptide receptor cDNA. Biochem. Biophys. Res. Comm. 1990; 168: 1103-1109.
5. Su SB, Gong W, Gao JL, Shen W, Murphy PM, Oppenheim JJ, Wang JM. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 1999; 189: 395-402.
6. Baggiolini M, Boulay F, Badwey JA, Cornutte JT. Activation of neutrophil leukocytes: chemoattractant receptors and respiratory burst. FASEB 1993; 7: 1004-1010.
7. Selvatici R, Falzarano S, Mollica A, Spisani S. Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils. Eur. J. Pharmacol. 2006; 534: 1-11.
8. Rathore RS. Conformational investigations on analogs of inflammation response inducing chemotactic tripeptide fMLP. Pept. Sci. 2005; 80: 651-664.
9. Cavicchioni G, Fraulini A, Falzarano S, Spisani S. Structure-activity relationship of for-L-Met L-Leu-L-Phe-OMe analogues in human neutrophils. Bioorg. Chem. 2006; 34: 298-318.
10. Torino D, Mollica A, Pinnen F, Feliciani F, Spisani S, Lucente G. Novel chemotactic For-Met-Leu-Phe-OMe (fMLF-OMe) analogues based on Met residue replacement by 4-amino-proline scaffold: synthesis and bioactivity. Bioorg. Med. Chem. 2009; 17: 251-259.
11. Mollica A, Paglialunga Paradisi M, Varani K, Spisani S, Lucente G. Chemotactic peptides: fMLF-OMe analogues incorporating proline-methionine chimeras as N-terminal residue. Bioorg. Med. Chem. 2006; 14: 2253-2265.
12. 3-peptides with proteinogenic side chains. Monosubstituted analogues of the chemotactic tripeptide For-Met-Leu-Phe-OMe. J. Pept. Sci. 2004; 10: 510-523.
13. Schiffmann E, Corcoran BA, Whal SM. N-formylmethionyl peptides as chemoattractants for leucocytes. Proc. Natl. Acad. Sci. (USA) 1975; 72: 1059-1062.
14. Day AR, Radding JA, Freer RJ, Showell HJ, Becker ER, Schiffmann E, Corcoran B, Aswanikumar S, Pert C. Synthesis and binding characteristics of an intrinsically radiolabeled chemotactic acyl tripeptide. Nα-formyl-norleucyl-leucyl-phenylalanine. FEBS Lett. 1977; 77: 291-294.
15. Spisani S, Turchetti M, Varani K, Falzarano S, Cavicchioni G. Hydrophilic residues at position 3 highlight unforeseen features of the fMLP receptor pocket. Eur. J. Pharmacol. 2003; 469: 13-19.
16. Derian CK, Solomon HF, Higgins III JD, Beblavy MJ, Santulli RJ, Bridger GJ, Pike MC, Kroon DJ, Fischman AJ. Selective inhibition of N-formylpeptide-induced neutrophil activation by carbamate-modified peptide analogues. Biochemistry 1996; 35: 1265-1269.
17. Le Y, Murphy PM, Wang JM. Formyl-peptide receptors revisited. Trends Immunol. 2002; 11: 541-548.
18. Freer RJ, Day AR, Radding JA, Schiffmann E, Aswanikumar S, Showell HJ, Becker EL. Further studies on the structural requirements for synthetic peptide chemoattractants. Biochemistry 1980; 19: 2404-2410.
19. Higgins JD III, Bridger GJ, Derian CK, Beblavy MJ, Hernandez PE, Gaul FE, Abrams MJ, Pike MC, Solomon HF. N-terminus urea-substituted chemotactic peptides: new potent agonists and antagonists toward the neutrophil fMLF receptor. J. Med. Chem. 1996; 39: 1013-1015.
20. Prossnitz ER, Ye RD. The N-formyl peptide receptor: a model for the study of chemoattractant receptor structure and function. Pharmacol. Ther. 1997; 74: 73-102.
21. Le Y, Oppenheim JJ, Wang JM. Pleiotropic roles of formyl peptide receptors. Cytokine Growth Factor Rev. 2001; 12: 91-105.
22. Dalpiaz A, Spisani S, Biondi C, Fabbri E, Nalli M, Ferretti ME. Studies on human neutrophil biological functions by means of formyl-peptide receptor agonists and antagonists. Curr. Drug Targets Immune Endocr. Metabol. Disord. 2003; 3: 33-42.
23. Lajoie G, Kraus JL. Rapid and efficient method for the N-formylation of C-blocked peptides. Peptides 1984; 5: 653-654.
24. El-Faham A, Albericio F. Peptide coupling reagents, more than a letter soup. Chem. Rev. 2011; 111: 6557-6602.
25. Dalpiaz A, Ferretti ME, Vertuani G, Traniello S, Scatturin A, Spisani S. C- and N-terminal residue effect on peptide derivatives' antagonism toward the formyl-peptide receptor. Eur. J. Pharmacol. 2002; 436: 187-196.
26. Selvatici R, Falzarano S, Traniello S, Pagani Zecchini G, Spisani S. Formylpeptides trigger selective molecular pathways that are required in the physiological functions of human neutrophils. Cell. Signal. 2003; 15: 377-383.
27. Cavicchioni G, Varani K, Niccoli S, Rizzuti O, Spisani S. An evaluation of fMLP pocket dimensions and features using formyltetrapeptides. J. Pept. Res. 1999; 54: 336-343.
28. Pagani Zecchini G, Nalli M, Mollica A, Lucente G, Paglialunga Paradisi M, Spisani S. Isopeptide bonds in chemotactic tripeptides. Synthesis and activity of lysine-containing fMLF analogs. J. Pept. Res. 2002; 59: 283-291.
29. Cavicchioni G, Fraulini A, Turchetti M, Varani K, Falzarano S, Pavan B. Biological activity of for-Met-Leu-Phe-OMe analogs: relevant substitutions specifically trigger killing mechanisms in human neutrophils. Eur. J. Pharmacol. 2005; 512: 1-8.